Drugs / Vevorisertib
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02761694 | Jun 2016 → Mar 2021 | cancer | ArQule, Inc. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vevorisertib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02761694 ↗ |
| Action | Inhibit | “pan-AKT inhibitor” PMID 36970876 ↗ Mar 2023 |
| Modality | Small molecule | — CHEMBL4802156 ↗ |